Factors Affecting Treatment Compliance of Patients With COPD During the COVID-19 Pandemic

Sibel Doğru; Füsun Fakılı; Sema Aytaç; Cengizhan Sezgi; Mahşuk Taylan; Nazan Gülhan Bayram; Meral Uyar

doi:10.58600/eurjther1752

Authors

Sibel Doğru Department of Pulmonary Medicine, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey https://orcid.org/0000-0002-0578-5025
Füsun Fakılı Department of Pulmonary Medicine, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey https://orcid.org/0000-0002-1602-5240
Sema Aytaç Nursing Department, Gaziantep University, Faculty of Health Sciences, Gaziantep, Turkey https://orcid.org/0000-0002-9892-3617
Cengizhan Sezgi Department of Pulmonary Medicine, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey https://orcid.org/0000-0002-5980-3874
Mahşuk Taylan Department of Pulmonary Medicine, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey https://orcid.org/0000-0003-4072-2270
Nazan Gülhan Bayram Department of Pulmonary Medicine, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey https://orcid.org/0000-0002-4692-2639
Meral Uyar Department of Pulmonary Medicine, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey https://orcid.org/0000-0002-3664-548X

DOI:

https://doi.org/10.58600/eurjther1752

Keywords:

Coronavirus, coronaphobia, depression, compliance, treatment, chronic obstructive pulmonary disease

Abstract

Objective: This study aimed to investigate the effects of difficulties experienced in the follow-up and treatment during the Coronavirus 2019 pandemic (COVID-19p), which included COVID-19 phobia and depression, on treatment compliance in patients with Chronic Obstructive Pulmonary Disease (COPD).

Methods: This study included 123 patients with COPD. The COVID-19 Phobia Scale (C19P-S), Beck Depression Inventory (BDI), and Medication Adherence Report Scale (MARS) were used to assess the patients.

Results: The mean age of patients with COPD was 64.56 ± 9.31 years. It was determined that our patients did not maintain regular outpatient follow-up mostly because of the fear of COVID-19 transmission (78.8%). Overall, 24% of our patients showed treatment noncompliance. A statistically significant relationship was found between COPD stages B and D and treatment compliance (p=0.01). Patients with frequent emergency department admissions (p = 0.01) and those with high BDI (p = 0.01) and C19P-S (p = 0.02) scores during the pandemic were found to have reduced treatment compliance.

Conclusion: Patients with COPD with COVID-19 phobia, and depression had reduced treatment compliance. İt is necessary to be aware of these conditions and to plan appropriate interventions.

Metrics

Metrics Loading ...

References

Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, Chan KY (2015) Global and regional estimates of COPD prevalence: Systematic review and meta–analysis. J Glob Health. 5(2):020415. https://doi.org/10.7189/jogh.05.020415

Humenberger M, Horner A, Labek A, Kaiser B, Frechinger R, Brock C, Lichtenberger P, Lamprecht B (2018) Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 18(1):1-6. https://doi.org/10.1186/s12890-018-0724-3

Asmundson GJ, Taylor S (2020) Coronaphobia: Fear and the 2019-nCoV outbreak. J Anxiety Disord. 70:102196. https://doi.org/10.1016/j.janxdis.2020.102196

Westgard BC, Morgan MW, Vazquez-Benitez G, Erickson LO, Zwank MD (2020) An analysis of changes in emergency department visits after a state declaration during the time of COVID-19. Ann Emerg Med. 76(5):595-601. https://doi.org/10.1016/j.annemergmed.2020.06.019

Agrawal S, Dróżdż M, Makuch S, Pietraszek A, Sobieszczańska M, Mazur G (2021) The assessment of fear of COVID-19 among the elderly population: A cross-sectional study. J. Clin. Med. 10(23):5537. https://doi.org/10.3390/jcm10235537

Gupta N, Malhotra N, Ish P (2021) GOLD 2021 guidelines for COPD—what’s new and why. Adv Respir Med. 89(3):344-346. https://doi.org/10.5603/ARM.a2021.0015

Arpaci I, Karataş K, Baloğlu M (2020) The development and initial tests for the psychometric properties of the COVID-19 Phobia Scale (C19P-S). Pers Individ Dif. 164:110108. https://doi.org/10.1016/j.paid.2020.110108

Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 8(1):77-100. https://doi.org/10.1016/0272-7358(88)90050-5

Hisli N (1989) Validity and reliability of Beck Depression Inventory for university students. Psikoloji Dergisi.;7(23):3-13.

Horne, R., and M. Hankins (2001) The MARS-5: an instrument to assess self-reported adherence to medication prescriptions. Unpublished manuscript, University of Brighton, UK.

Şen ET, Sertel BÖ, Sindel D (2019) İlaç uyumunu bildirim ölçeği’nin türkçe uyarlamasının geçerlik ve güvenirlik çalışması. Journal of Istanbul Faculty of Medicine 82(1):52-61. https://doi.org/10.26650/IUITFD.413637

Sjölander M, Eriksson M, Glader EL (2013) The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey. BMJ open. 3(9):e003551. https://doi.org/10.1136/bmjopen-2013-003551

Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA (2020) Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 8(7):2384. https://doi.org/10.1016/j.jaip.2020.04.053

Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R., Vines DL, Sikkema OJ, Gardner DD, Wilkins RL (2008) Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 3(3):371-384. https://doi.org/10.2147/copd.s3036

Ágh T, Udvardy MA (2012) Adherence to Therapy in Chronic Obstructive Pulmonary Disease.

McAuley H, Hadley K, Elneima O, Christopher EB, Rachael AE, Michael CS, Neil J G (2021) COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Res. 7(1). https://doi.org/10.1183/23120541.00718-2020

Bourbeau J, Bartlett SJ (2008) Patient adherence in COPD. Thorax. 63(9):831-838. https://doi.org/10.1136/thx.2007.086041

Chagué F, Boulin M, Eicher JC, Bichat F, Saint Jalmes M, Cransac‐Miet A, Soudry‐Faure A, Danchin N, Cottin Y, Zeller M (2020) Impact of lockdown on patients with congestive heart failure during the coronavirus disease 2019 pandemic. ESC heart fail. 7(6):4420-4423. https://doi.org/10.1002/ehf2.13016

Degli EL, Buda S, Nappi C, Paoli D, Perrone V (2020) Network Health-DB. Implications of covid-19 infection on medication adherence with chronic therapies in italy: A proposed observational investigation by the fail-to-refill project. Risk Manag Healthc Policy. 3179-3185. https://doi.org/10.2147/RMHP.S265264

Park S, Kang Y (2017) Symptom experience, self-efficacy, depression, and medication adherence in patients with chronic obstructive pulmonary disease. J Korean Clin Nurs Res. 23(2):170-178. https://doi.org/10.22650/JKCNR.2017.23.2.170

Zhang HQ, Lin JY, Guo Y, Pang S, Jiang R, Cheng QJ (2020) Medication adherence among patients with chronic obstructive pulmonary disease treated in a primary general hospital during the COVID-19 pandemic. Ann Transl Med. 8(18):1179. https://doi.org/10.21037/atm-20-6016

Chen R, Gao Y, Wang H, Shang H, Xuan J (2020) Association between adherence to maintenance medication in patients with COPD and acute exacerbation occurrence and cost in China: a retrospective cohort database study. Int J Chron Obstruct Pulmon Dis. 963-971. https://doi.org/10.2147/COPD.S234349

Lee SM, Kang WS, Cho AR, Kim T, Park JK (2018) Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients. Compr Psychiatry. 87:123-127. https://doi.org/10.1016/j.comppsych.2018.10.003